Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Cellectar Biosciences, Inc. Major Shareholding Notification 2021

Jul 8, 2021

35021_mrq_2021-07-08_87332faf-dfec-416a-8438-042e2a06acdc.zip

Major Shareholding Notification

Open in viewer

Opens in your device viewer

SC 13G 1 cellectar_13g.htm SC 13G Field: Rule-Page

Field: /Rule-Page

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934

Cellectar Biosciences, Inc.

Field: Rule-Page

Field: /Rule-Page

(Name of Issuer)

Common Shares

Field: Rule-Page

Field: /Rule-Page

(Title of Class of Securities)

15117F500

Field: Rule-Page

Field: /Rule-Page

(CUSIP Number)

June 30, 2021

Field: Rule-Page

Field: /Rule-Page

(Date of Event which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed: o Rule 13d-1(b) x Rule 13d-1(c) o Rule 13d-1(d)

  • The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

Field: Rule-Page

Field: /Rule-Page Field: Page; Sequence: 1

Field: /Page

CUSIP No. 15117F500 13G Page 2 of 9 Pages

| 1. | NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Rosalind Advisors, Inc. | | --- | --- | | 2. | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions) (a) o (b) o | | 3. | SEC USE ONLY | | 4. | CITIZENSHIP OR PLACE OF ORGANIZATION ONTARIO, CANADA |

| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | SOLE VOTING POWER 0 | | --- | --- | | 6. | SHARED VOTING POWER 3,207,160 | | 7. | SOLE DISPOSITIVE POWER 0 | | 8. | SHARED DISPOSITIVE POWER 3,207,160 |

| 9. | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 3,207,160 | | --- | --- | | 10. | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (see instructions) o | | 11. | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 6.0% 1 | | 12. | TYPE OF REPORTING PERSON (see instructions) CO |

Field: Rule-Page

Field: /Rule-Page

1 This percentage is calculated based upon 52,726,278 shares of the Issuer’s common stock outstanding as of May 5, 2021 in accordance with 10-Q filed on May 10, 2021.

Field: Page; Sequence: 2

Field: /Page

CUSIP No. 15117F500 13G Page 3 of 9 Pages

| 1. | NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Steven Salamon | | --- | --- | | 2. | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions) (a) o (b) o | | 3. | SEC USE ONLY | | 4. | CITIZENSHIP OR PLACE OF ORGANIZATION ONTARIO, CANADA |

| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | SOLE VOTING POWER 0 | | --- | --- | | 6. | SHARED VOTING POWER 3,207,160 | | 7. | SOLE DISPOSITIVE POWER 0 | | 8. | SHARED DISPOSITIVE POWER 3,207,160 |

| 9. | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 3,207,160 | | --- | --- | | 10. | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (see instructions) o | | 11. | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 6.0% 1 | | 12. | TYPE OF REPORTING PERSON (see instructions) IN |

Field: Page; Sequence: 3

Field: /Page

CUSIP No. 15117F500 13G Page 4 of 9 Pages

| 1. | NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Gilad Aharon | | --- | --- | | 2. | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions) (a) o (b) o | | 3. | SEC USE ONLY | | 4. | CITIZENSHIP OR PLACE OF ORGANIZATION ONTARIO, CANADA |

| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | SOLE VOTING POWER 0 | | --- | --- | | 6. | SHARED VOTING POWER 3,207,160 | | 7. | SOLE DISPOSITIVE POWER 0 | | 8. | SHARED DISPOSITIVE POWER 3,207,160 |

| 9. | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 3,207,160 | | --- | --- | | 10. | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (see instructions) o | | 11. | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 6.0% 1 | | 12. | TYPE OF REPORTING PERSON (see instructions) IN |

Field: Page; Sequence: 3

Field: /Page

CUSIP No. 15117F500 13G Page 5 of 9 Pages

| 1. | NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Rosalind Master Fund L.P. | | --- | --- | | 2. | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions) (a) o (b) o | | 3. | SEC USE ONLY | | 4. | CITIZENSHIP OR PLACE OF ORGANIZATION CAYMAN ISLANDS |

| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | SOLE VOTING POWER 0 | | --- | --- | | 6. | SHARED VOTING POWER 3,207,160 | | 7. | SOLE DISPOSITIVE POWER 0 | | 8. | SHARED DISPOSITIVE POWER 3,207,160 |

| 9. | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 3,207,160 | | --- | --- | | 10. | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (see instructions) o | | 11. | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 6.0% 1 | | 12. | TYPE OF REPORTING PERSON (see instructions) PN |

Field: Page; Sequence: 4

Field: /Page

CUSIP No. 15117F500 13G Page 6 of 9 Pages

Item 1.

(a) Name of Issuer: CELLECTAR BIOSCIENCES, INC.
(b) Address
of Issuer’s Principal Executive Offices 100 Campus Drive, Florham Park, New
Jersey 07932

Item 2.

| (a) | Name of Person Filing Rosalind Advisors, Inc. (“Advisor” to RMF) Rosalind Master Fund L.P. (“RMF”) Steven Salamon (“President”) Steven Salamon is the portfolio manager of the Advisor which advises RMF. Gilad Aharon is the portfolio manager and member of the Advisor which advises RMF. | | --- | --- | | (b) | Address of the Principal Office or, if none, residence Rosalind Advisors, Inc. 175 Bloor Street East Suite 1316, North Tower Toronto, Ontario M4W 3R8 Canada Rosalind Master Fund L.P. P.O. Box 309 Ugland House, Grand Cayman KY1-1104, Cayman Islands Steven Salamon 175 Bloor Street East Suite 1316, North Tower Toronto, Ontario M4W 3R8 Canada Gilad Aharon 175 Bloor Street East Suite 1316, North Tower Toronto, Ontario M4W 3R8 Canada | | (c) | Citizenship Rosalind Advisors, Inc.: Ontario, Canada Rosalind Master Fund L.P.: Cayman Islands Steven Salamon: Ontario, Canada Gilad Aharon: Ontario, Canada | | (d) | Title of Class of Securities Common Stock | | (e) | CUSIP Number 15117F500 |

Field: Page; Sequence: 5

Field: /Page

CUSIP No. 15117F500 13G Page 7 of 9 Pages

Item 3. If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

| (a) | o | Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o). | | --- | --- | --- | | (b) | o | Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c). | | (c) | o | Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c). | | (d) | o | Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8). | | (e) | o | An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E); | | (f) | o | An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F); | | (g) | o | A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G); | | (h) | o | A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); | | (i) | o | A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); | | (j) | o | Group, in accordance with §240.13d-1(b)(1)(ii)(J). |

Item 4. Ownership.

Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

| (a) | Amount beneficially owned: Rosalind Master Fund L.P. is the record owner of 3,207,160 shares of common stock. Rosalind Advisors, Inc. is the investment advisor to RMF and may be deemed to be the beneficial owner of shares held by RMF. Steven Salamon is the portfolio manager of the Advisor and may be deemed to be the beneficial owner of shares held by RMF. Notwithstanding the foregoing, the Advisor and Mr. Salamon disclaim beneficial ownership of the shares. | | --- | --- | | (b) | Percent of class: Rosalind Advisors, Inc. – 6.0% Rosalind Master Fund L.P. – 6.0% Steven Salamon – 6.0% Gilad Aharon – 6.0% |

Field: Page; Sequence: 6

Field: /Page

CUSIP No. 15117F500 13G Page 8 of 9 Pages

(c)
(i) Shared
power to vote or to direct the vote Rosalind Advisors,
Inc. – 3,207,160 Rosalind Master
Fund L.P. – 3,207,160 Steven Salamon
– 3,207,160 Gilad Aharon
  • 3,207,160 | | (ii) | Sole power to dispose or to direct the disposition of – 0 | | (iii) | Shared power to dispose or to direct the disposition of Rosalind Advisors, Inc. – 3,207,160 Rosalind Master Fund L.P. – 3,207,160 Steven Salamon – 3,207,160 Gilad Aharon
  • 3,207,160 |

Instruction . For computations regarding securities which represent a right to acquire an underlying security see §240.13d-3(d)(1).

Item 5. Ownership of Five Percent or Less of a Class.

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following o .

Instruction . Dissolution of a group requires a response to this item.

Item 6. Ownership of More than Five Percent on Behalf of Another Person.

Item 7 – 9. Not Applicable

Field: Page; Sequence: 7

Field: /Page

CUSIP No. 15117F500 13G Page 9 of 9 Pages

Item 10. Certification.

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

7/8/2021
Date
/s/
Steven Salamon
Signature
Steven
Salamon/President Rosalind Advisors, Inc.
Name/Title